Hotelchamp, an Amsterdam, The Netherlands-based smart technology startup that provides a software platform that aims to enhance the relationship between guests and hotels, recently raised €2.25M in the second tranche of its seed funding round, which now totals €4m.
Bidroom.com, an Amsterdam, The Netherlands-based hotel booking startup, secured an investment from Samih Sawiris.
Viroclinics, a Rotterdam, The Netherlands-based clinical research organization, was acquired by Parcom Capital.
SendCloud, an Eindhoven, The Netherlands-based e-commerce shipping tool provider, raised €5m in funding.
Hotelchamp, an Amsterdam, The Netherlands-based smart technology service that enhances the relationship between guests and hotels to drive an increase in direct bookings, raised additional €2.25M in seed funding.
Waterland Private Equity Investments, a Dutch private equity firm, closed its seventh fund at €2 billion.
Contentoo, an Amsterdam, The Netherlands-based platform for specialized B2B copywriters, received an investment from angel investors Frans van Hulle and Bas Offers.
Global investment firm Marlin Equity Partners is to acquire Abit Europe Group, a provider of claims and credit management, and risk and impairment software and services.
Polarsteps, an Amsterdam, The Netherlands-based travel tracking platform, raised €900k in seed funding.
Main Capital Partners, a private equity and mezzanine capital investor, has held an initial closing of Main Capital V, above €100m.
Nordea, the largest bank in the Nordic region, and AlpInvest, a global private equity investor, have launched a new co-investment fund.
Scenic Biotech, an Amsterdam, the Netherlands-based therapeutics company, raised €6.5m in Series A financing.
BioGeneration Ventures (BGV), a Naarden, The Netherlands-based early stage life sciences venture capital firm with funds focused on European biotechnology companies, received an additional investment, taking the total capital commitments to €66m, out of a maximum €75m.
Harver, an Amsterdam, The Netherlands-based HR tech startup, raised $8.1m in Series A funding.
VarmX, a Leiden, Netherlands-based biotech company focusing on the development of therapies in the field of hemostasis and thrombosis, closed its seed financing round.